<DOC>
	<DOC>NCT01074619</DOC>
	<brief_summary>The purpose of this study is to determine if memantine is effective in the treatment on cognitive disorders of Relapsing - Remitting multiple sclerosis. m</brief_summary>
	<brief_title>Study on Cognitive Disorders of Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Remitting Multiple Sclerosis defined by Mc Donald et al., 2001 Patient with authorised immunomodulator treatment or oral immunosuppressive therapy during more than three months: Bétâ Interferon, glatiramer acetate, azathioprine, methotrexate, mycophenolate mofetil, treatment by monoclonal antibody I.V. or antiVLA4, natalizumab (Tysabri) Patient having benefited, possibly, of following treatments : mitoxantrone, cyclophosphamide, cyclosporine, generalpurpose immunoglobulins, only if the treatment is ended more of 6 months before the inclusion. EDSS score ≤ 5.5 DRS score ≥ 130 PASAT 3s score &gt; 15 and &lt; median / control subjects according to 2 age brackets, sex, school level. Signed the informed consent form. Effective contraception for women in age to procreate Progressive form MS MS relapse of less of 4 weeks. IV or oral corticoid treatment in the month preceding the screening Medicinal treatments or non medicinal in cognitive or psychologystimulant aim in the 3 months before the screening Tumoral form MS visible in the MRI. Depressive syndrome (MADRS score &gt; 19). Quite other diagnosed psychiatric pathology Known allergy or quite contraindication in memantin : renal or hepatic insufficiency, turned out epileptic disease, treatment by ketamine, amantadin, dextromethorphan, LDopa, dopaminergic agonist, barbituric, neuroleptic, 3,4diaminopyridine, lithium, cimetidine, ranitidine, procainamide, quinine, nicotine, hydrochlorthiazide and ally, phenytoin, modafinil. Recent treatment (less of 4 weeks) by antidepressants and/or anxiolytics. Pregnancy or feeding. Minor or Major "protected by the law" patient Uncontrolled diet. Patient having benefited of one psychometric assessment(including in particular tests planned in the protocol) since less of one year.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>